A. Uren1, N. Cotterill1, C. Harding2, C. Hillary3, C. Chapple3, M

Slides:



Advertisements
Similar presentations
Advances in the Management of BPH
Advertisements

"What I really needed was the truth" Exploring the information needs of people with CRPS. Sharon Grieve 1,2, Jo Adams 2, Candida McCabe 1,3. 1 Royal National.
A feasibility study to explore patient, clinician and GP decision making of acute recurrent tonsillitis for NATTINA: The NAtional Trial of Tonsillectomy.
Authors and affiliation Research, University of Sheffield, 3 East Midlands Ambulance Service Study flow Conclusion In addition to measures relating to.
Development and initial validation of the ‘Bristol Impact of Hypermobility’ (BIoH) questionnaire ST Palmer a, F Cramp a, R Lewis b, G Gould c, E Clark.
DEVELOPMENT OF A PREFERENCE-BASED, CONDITION SPECIFIC PATIENT REPORTED OUTCOME MEASURE FOR USE WITH VENOUS ULCERATION Simon Palfreyman 1, John E Brazier.
Urodynamic Findings and Diagnosis in Aging People
Pradeep P Research Scholar Guide Dr. N.S. Harinarayana.
Executive Functioning Skills Deficits in university students with Developmental Co-ordination Disorder (DCD) Kirby, A., Thomas, M. & Williams, N.
Are Patients Admitted to the Virtual Ward Satisfied with the Intervention of the Community Matron in their Care Pathway? Geraldine Rodgers Dr. Maria Ponto.
National Obesity Observatory The Standard Evaluation Framework National Obesity Observatory The Standard Evaluation Framework Kath Roberts
FDA Approach to Review of Outcome Measures for Drug Approval and Labeling: Content Validity Initiative on Methods, Measurement, and Pain Assessment in.
Urology Update Sanofi- Aventis
The Practical Art of Endpoint Selection: Industry Perspectives A View from the Pharma Industry of the FDA Guidance on PROs Glenn A. Phillips, Ph.D. Director.
“The Effect of Patient Complexity on Treatment Outcomes for Patients Enrolled in an Integrated Depression Treatment Program- a Pilot Study” Ryan Miller,
SEER Provided Data Mohammad Afnan Baqai 12/3/2009.
Schizophrenia – what’s wrong with this joke?. What the Specification Says: Candidates will be expected to: develop knowledge and understanding of theories.
Do Instrumental Activities of Daily Living Predict Dementia at 1- and 2- Year Follow-Up? Findings from the Development of Screening Guidelines and Diagnostic.
Optimization of psychotropic drug prescription in nursing home patients with dementia: the PROPER study (PRescription Optimization of Psychotropic drugs.
Abstract Title of Poster Authors Department / Division, Advocate Children’s Hospital Title of Poster Authors Department / Division, Advocate Children’s.
Collecting data about service user satisfaction November 4th 2013 Workshop in London.
Can an evidence based coaching intervention improve outcomes for older people with congestive heart failure (CHF) and their informal caregivers within.
CoRPS London 26 & 27 October 2010 Center of Research on Psychology in Somatic diseases Understanding PRO in hematological disorders: Do we have a consensus?
Instrument Development and Psychometric Evaluation: Scientific Standards May 2012 Dynamic Tools to Measure Health Outcomes from the Patient Perspective.
Noninvasive Urodynamic Evaluation Carlos Arturo Levi D’Ancona, Jose Bassani, João Carlos Almeida Division of Urology and Bioengineering, University of.
Association of Body Mass Index (BMI) and Depression Severity
Remove this white box to use the template
Nocturia vescica, prostata o sintomo sistemico ?
Borderline personality disorder and personal distress Shalini Choudhary & Komilla Thapa University of Allahabad, Allahabad, India Borderline Personality.
Development of PRO Content
International Neurourology Journal 2015;19:
Urology & Nephrology Center, Mansoura, EGYPT
Assessment of sexual function in women attending a urogynaeoclogy clinic using an electronic questionnaire TG Gray*, J Money-Taylor, PC Campbell, SC Radley.
The Southampton Stroke Self-Management Questionnaire (SSSMQ)
Living with vascular disease: A qualitative study.
International Neurourology Journal 2015;19:
#96 Roles Of Urodynamics In the Assessment of Post Radical
A systematic review of the relationship between substance abuse and psychotropic medication adherence: opportunities to improve outcomes for patients with.
Development of an electronic personal assessment questionnaire to capture the impact of living with a vascular condition: ePAQ-VAS Patrick Phillips, Elizabeth.
Integrated microRNA-mRNA profiling identifies molecular biomarkers in bladder outlet obstruction-induced lower urinary tract dysfunction Fiona C. Burkhard1,
Remove this white box to use the template
1Bristol Urological Institute 2Astellas Pharma Europe B.V.
Minoru Miyazato, Asuka Ashikari, Takuma Oshiro, and Seiichi Saito
How should we test for pre-term labour
Remove this white box to use the template
Management of Male OAB; Current Status in Japan
UKCS 2018 Multivariate analysis of variance for maximising the diagnosing accuracy in differentiating DU from BOO in males Presentation by Rui Li Supervisors:
Progressive Multiple Sclerosis and incontinence:
Bladder Dysfunction Associated With Parkinson’s Disease
Gottesman and Shields (1966)
Remove this white box to use the template
Remove this white box to use the template
Rhematoid Rthritis Respiratory disorders
Grampian COPD MCN Delivering Spirometry in a Community Pharmacy setting, a rural solution? Small I (1,2), Clelland J (1,2), Robertson W (1), Freeman D.
Revision of essential basic urological science
ICI-RS Pre-meeting Rui Li
Nat. Rev. Urol. doi: /nrurol
Volume 56, Issue 1, Pages (July 2009)
Volume 72, Issue 3, Pages (September 2017)
Volume 69, Issue 2, Pages (February 2016)
Portable Biofeedback for Bladder Control
Spanish and English Neuropsychological Assessment Scales - Guiding Principles and Evolution Friday Harbor Psychometrics Workshop 2005.
Nat. Rev. Urol. doi: /nrurol
by Simon Gilbody, David Richards, and Michael Barkham
Unit 4 - A06 – Review Grade Criteria To get a c
ICS TEACHING MODULE Urodynamics in children Part 2
Proposal of a new scoring formula for the DLQI in psoriasis
Connecting Foster and Kinship Carers SA Morning Tea: Fetal Alcohol Spectrum Disorders Stewart McDougall.
The prevalence of psychological co-morbidity in people with vitiligo: a systematic review and meta-analysis O. Osinubi, M.J. Grainge, L. Hong, A. Ahmed,
Presentation transcript:

Qualitative development of a new patient reported outcome measure for underactive bladder A. Uren1, N. Cotterill1, C. Harding2, C. Hillary3, C. Chapple3, M. Klaver4, D. Bongaerts4, Z. Hakimi4, P. Abrams1 1Bristol Urological Institute, UK; 2Freeman Hospital, Newcastle; 3Royal Hallamshire Hospital, Sheffield; 4Astellas Pharma Europe B.V., Leiden, The Netherlands. BACKGROUND Detrusor underactivity (DU) is a common but poorly understood lower urinary tract dysfunction diagnosed during a urodynamic assessment. Underactive bladder (UAB) is currently proposed as a term to describe the symptoms and signs associated with DU : The lack of an existing patient reported outcome measure (PROM), validated in the target population and complying with current regulatory standards, supports the development of a novel PROM for the assessment of the symptoms, signs and impact of underactive bladder. This is the qualitative development of a PROM, the ICIQ-UAB, which is being developed in-line with current FDA guidelines for use in research and clinical practice. “A symptom complex suggestive of detrusor underactivity and is usually characterised by prolonged urination time with or without a sensation of incomplete bladder emptying, usually with hesitancy, reduced sensation on filling, and a slow stream.” Chapple et al. 2015 METHODS In-depth concept elicitation (CE) interviews were conducted with patients in whom a primary DU diagnosis was given at urodynamics. Interviews continued until no new concepts were mentioned during further interviews (data saturation achieved). Following detailed qualitative analysis of the transcripts, a draft PROM was developed in which each item corresponded to a symptom, sign or behaviour reported by patients. Each item was worded with idiomatic language used by the patient population. Cognitive debriefing interviews were scheduled and iterative revisions of the PROM made, until items were interpreted by patients as intended and no further changes were deemed necessary. RESULTS Concept elicitation interviews were conducted in Bristol and cognitive debriefing interviews were held in Bristol, Sheffield or Newcastle hospitals, UK. All interviews were performed with patients diagnosed with DU, with or without coexisting urological conditions (table 1). More than 30 lower urinary tract symptoms, signs or behaviours were identified, having a broad impact on quality of life. The first version of the PROM contained 37 items which was refined to 31 items (see figure 1 and 2) based on feedback from the cognitive debriefing interviews. Table 1. Sample population characteristics. Examples of quotes from patients from the CE interviews: Sample Characteristic Concept elicitation interviews Cognitive debriefing interviews Total sample (n) 44 37* DU (only) (n) 19 14 DU + co-existing urological conditions (n) 25 22 Males (n) 29 (66%) 28 (76%) Mean age and range (years) 64 (27-88) 66 (26-88) Ethnicity White British (100%) Education background Varied Intermittent self-catheterisation (n) 23 (52%) current or historical 11 (30%) current PVR >30ml (n) 34 (77%) Figure 1. Items included in draft PROM. *Includes one practice interview with a patient with a diagnosis of bladder outlet obstruction. Figure 2. An example of an item in the draft PROM following the cognitive debriefing interviews. CONCLUSIONS Concept elicitation and cognitive debriefing interviews have been carried out in a large group of patients with DU. The result is a novel and comprehensive version of the PROM for the evaluation of UAB symptoms and its impact on quality of life. Further concept exploration in Japan and the US, and assessment of its psychometric properties will refine items for inclusion in the final PROM. Reference Chapple, C.R., Osman, N. I., Birder, L. et al. (2015). The Underactive Bladder: A New Clinical Concept? Eur Urol 68(3): 351-3. Sponsored by Astellas Pharma Europe B.V.